Evidence map›Paper›PMID 37887397›Full record

ReviewMetabolites2023

The Impact of Tannic Acid Consumption on Bone Mineralization.

Anna Winiarska-Mieczan, Siemowit Muszyński, Ewa Tomaszewska, Małgorzata Kwiecień, Janine Donaldson, Agnieszka Tomczyk-Warunek, Tomasz Blicharski

Abstract readReview
In one paragraph

Review in Metabolites, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anna Winiarska-MieczanDepartment of Bromatology and Food Physiology, Institute of Animal Nutrition and Bromatology, University of Life Sciences in Lublin, 20-950 Lublin, Poland.ORCID 0000-0003-1981-7005
Siemowit MuszyńskiDepartment of Biophysics, University of Life Sciences in Lublin, 20-950 Lublin, Poland.ORCID 0000-0002-4118-6302
Ewa TomaszewskaDepartment of Animal Physiology, University of Life Sciences in Lublin, 20-950 Lublin, Poland.ORCID 0000-0002-7574-2653
Małgorzata KwiecieńDepartment of Animal Nutrition, Institute of Animal Nutrition and Bromatology, University of Life Sciences in Lublin, 20-950 Lublin, Poland.ORCID 0000-0002-8047-8682
Janine DonaldsonSchool of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Parktown, Johannesburg 2193, South Africa.ORCID 0000-0001-5072-016X
Agnieszka Tomczyk-WarunekLaboratory of Locomotor System Research, Department of Rehabilitation and Physiotherapy, Medical University in Lublin, 20-090 Lublin, Poland.
Tomasz BlicharskiDepartment of Orthopaedics and Rehabilitation, Medical University in Lublin, 20-090 Lublin, Poland.ORCID 0000-0001-9747-8817

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tannic acid (TA) is an organic compound belonging to the tannin group. Like other tannins, it has an affinity for endogenous proteins, including digestive enzymes, which can result in the reduced digestibility and absorption of nutrients. It can also form complexes with mineral components, reducing their absorption. In some cases, this can be beneficial, such as in the case of toxic metals, but sometimes it may have a detrimental effect on the body when it involves essential mineral components like Ca, P, Mg, Na, K, or Fe. Therefore, the impact of TA on bone health should be considered from both perspectives. This relatively short review summarizes the available information and research findings on TA, with a particular focus on its potential impact on bone health. It is worth noting that future research and clinical studies may provide more detailed and precise information on this topic, allowing for a better understanding of the role of TA in maintaining the integrity of the musculoskeletal system. Despite its brevity, this paper represents a valuable contribution to the analysis of the potential benefits and challenges associated with TA in the context of bone health. We anticipate that future research will continue along this important research line, expanding our knowledge of the influence of this compound on the skeletal system and its potential therapeutic applications.

Indexed as

bonesosteoporosistannic acid

Identifiers

PMID37887397
PMCPMC10609055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.